Showing results (2191-2200 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|May 10, 2017
Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapyJason N Barreto, Kristen B McCullough, Candy S Peskey, et al.
Leukemia & Lymphoma|June 2, 2017
Current perspectives on the role of chemotherapy in chronic lymphocytic leukemiaClemens-Martin Wendtner, Michael Gregor
Leukemia & Lymphoma|June 3, 2017
Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myelomaGiuseppe Milone, Massimo Martino, Salvatore Leotta, et al.
Leukemia & Lymphoma|June 7, 2017
Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treatAshish Gautam, Yanyan Zhu, Esprit Ma, et al.
Leukemia & Lymphoma|June 21, 2017
Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of managementBronwyn C Thorp, Xavier Badoux
Leukemia & Lymphoma|May 16, 2017
Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discoverySarah Chuzi, Brady L Stein
Leukemia & Lymphoma|May 16, 2017
Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinibKhai Li Chai, Gail Rowan, John F Seymour, et al.
Leukemia & Lymphoma|May 17, 2017
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapyAlessandro Busca, Federica Lessi, Luisa Verga, et al.
Leukemia & Lymphoma|May 17, 2017
High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)Nina D Wagner-Johnston, Shelly Lensing, Ariela Noy, et al.
Leukemia & Lymphoma|May 17, 2017
Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistanceBarbara Muz, Hubert D Kusdono, Feda Azab, et al.
Pageof 1,001